Presenter is Andrew J. Saxon, M.D.
Professor and Director, Addiction Psychiatry Residency Training
University of Washington
Director, Addictions Treatment Center at the VA Puget Sound Health Care System
Most patients with opioid addiction also have problematic use of other substances including alcohol, stimulants, sedatives, and tobacco. For many patients stabilization of opioid addiction with buprenorphine in office-based practice also leads to a dramatic reduction in use of other substances. On occasion the use of other substances interferes with success of office-based buprenorphine.
Addressing problematic substance use in the context of office-based practice poses a number of challenges. This webinar will provide an overview of pharmacotherapeutic and behavioral interventions that could be used or adapted for office-based practice.